The effect of SGN-75, a novel antibody-drug conjugate (ADC), in treatment of patients with renal cell carcinoma (RCC) or non-Hodgkin lymphoma (NHL): A phase I study Meeting Abstract
| Authors: | Thompson, J. A.; Forero-Torres, A.; Heath, E. I.; Ansell, S. M.; Pal, S. K.; Infante, J. R.; De Vos, S.; Hamlin, P. A.; Zhao, B.; Klussman, K.; Whiting, N. C. |
| Abstract Title: | The effect of SGN-75, a novel antibody-drug conjugate (ADC), in treatment of patients with renal cell carcinoma (RCC) or non-Hodgkin lymphoma (NHL): A phase I study |
| Meeting Title: | 47th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 29 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2011 Jun 3-7 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2011-05-20 |
| Language: | English |
| ACCESSION: | WOS:000208880301500 |
| DOI: | 10.1200/jco.2011.29.15_suppl.3071 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 3071 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
